Immune dysregulation in cancer patients developing immune-related adverse events
2018 · British Journal of Cancer · 180 citations
https://doi.org/10.1038/s41416-018-0155-1
S
Shaheen Khan
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
60
Papers
2.8K
Citations
18
h-index
21
i10-index
Shaheen Khan is an academic researcher from Royal Adelaide Hospital. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Colorectal Cancer Treatments and Studies & Immune Cell Function and Interaction. The author has an h-index of 18, co-authored 51 publications.
ORCID: 0009-0008-7691-9810Papers by this author
worksA Phase I trial of B-cell depletion with anti-CD20 monoclonal antibody (rituximab) in the treatment of systemic lupus erythematosus
2003 · Arthritis Research · 12 citations
https://doi.org/10.1186/ar830
Carboxymethyl-cellulose/starch/copper-oxide nanocomposite hydrogel green synthesis for organic pollutants photocatalytic degradation that supports health applications
2025 · Colloids and Surfaces A Physicochemical and Engineering Aspects · 8 citations
https://doi.org/10.1016/j.colsurfa.2025.136919
KLF13 promotes SLE pathogenesis by modifying chromatin accessibility of key proinflammatory cytokine genes
2024 · Communications Biology · 3 citations
https://doi.org/10.1038/s42003-024-07099-0
Exploration of cerium doped down conversion microcrystals for enhanced photovoltaic performance and UV light stability of hybrid perovskite solar cells
2025 · Solar Energy · 3 citations
https://doi.org/10.1016/j.solener.2025.113622
Real-world impact of adjuvant anti-PD-1 therapy on survival in Danish resected stage IIIA-D melanoma patients
2025 · EJC Skin Cancer · 0 citations
https://doi.org/10.1016/j.ejcskn.2025.100553
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat